Market Insights

All days

20 MAY 2021

Market Insights

PRESENTATION - ON DEMAND

The Manufacturing Roadmap for Africa

Africa is an exciting emerging market with significant investment potential. While pharmaceuticals are currently manufactured across South Africa, Kenya, Nigeria, Algeria, Morocco and Egypt, the continent still relies on imports for over 70% of pharmaceutical and medical consumables.

Discussion points

Current outlook for African pharma manufacturing
What are the obstacles to growth?
How can the right infrastructure for domestic manufacturing be nurtured?
Facilitating R&D and innovation

PRESENTATION - ON DEMAND

How will the New Administration Impact the US Pharma Market?

In January 2021, the U.S. Department of Health and Human Services and the Food and Drug Administration started operating under the new Biden Administration.

As always, Pharma played an integral part of the 2020 campaign, this session will deep-dive into the changes we can expect for the US market.

Discussion points

An important component of the 2020 campaign, what will be the new Administration's approach to tackling COVID-19 ?
Pricing and reimbursement strategies
What will the impact be on patients and payers?
The realities of reshoring manufacturing, can we expect to see reduced reliance on the East for essential medicines?
The R&D and innovation landscape

PRESENTATION - ON DEMAND

SOLD

Sustainability: Opportunities & Challenges for a Circular Economy in Pharma

The Pharma industry is not exempt from concerns regarding its contribution to the climate emergency. Concerns over water consumption, pharmaceuticals in the environment (PiE), antimicrobial resistance (AMR) and the industry’s reliance on fossil fuels have put manufacturing practices in the spotlight, and taking a more conscious approach to manufacturing practices can be an important differentiator for Pharma companies in todays environment.

Discussion points

Addressing the climate emergency’s effect on public health
Reuse-Recycle- what role can waste management play in improving secondary raw materials?
Aligning goals and collaboration across the value chain
Standardizing Sustainability: Industry progresses on setting sustainability standards

18 MAY 2021

PRESENTATION - ON DEMAND

Outsourcing Biologics Manufacturing to China:
Opportunities, Challenges, and Trends

Regulatory reform in China is creating interesting opportunities for both domestic and international CDMOs to enter the market - particularly in the monoclonal antibody space.

Will China become an exciting new destination for the manufacture of innovator products and future blockbusters?

Discussion points:

Brief History of China's Biologics CDMO market
Regulatory reforms open doors for CDMOs
Innovation and Outsourcing Trends for Bioprocessing
Why outsource to China?
MNC vs. domestic CDMO

20 MAY 2021

PRESENTATION - ON DEMAND

Exploring the Promise of LatAm Pharma

Latin America is a diverse market with a huge population that has commanded the attention of pharma companies as one to watch. This session will explore how the potential of this dynamic market can be tapped into.

Overview of the current market opportunities & challenges across key markets - Brazil, Mexico, Chile, Colombia, Argentina and Central America.
Key therapy areas & most promising markets
Innovation landscape
Potential drivers to increasing internationalization of the LatAm Pharma Market
What has been the impact of the pandemic on the Latam pharmaceutical market?

SOLD

PRESENTATION - ON DEMAND

Beyond Brexit: The Future of British Pharma

The United Kingdom left the European Union on December 31st 2020. Before this, the EMA had already relocated its European HQ from London to Amsterdam, and there was considerable uncertainty on how the European Pharma Market would be impacted. This session will provide an analysis of the challenges presented by Brexit, and the impact on British Pharma.

Discussion points:

What is the impact of the UK leaving the UK on Pharma to date? What has changed?
Security of supply for medical and pharmaceutical products
How are manufacturers going to ensure continuity of supply in a post-Brexit world?
How will innovation be impacted?
What are the long-term implications of Brexit?